Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

291 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and cost of HMG-CoA reductase inhibitors in the treatment of patients with primary hyperlipidemia.
Perreault S, Levinton C, Le Lorier J. Perreault S, et al. Can J Clin Pharmacol. 2000 Autumn;7(3):144-54. Can J Clin Pharmacol. 2000. PMID: 11044760
A head-to-head comparison of the cost effectiveness of HMG-CoA reductase inhibitors and fibrates in different types of primary hyperlipidemia.
Perreault S, Hamilton VH, Lavoie F, Grover S. Perreault S, et al. Cardiovasc Drugs Ther. 1997 Jan;10(6):787-94. doi: 10.1007/BF00053037. Cardiovasc Drugs Ther. 1997. PMID: 9110123 Clinical Trial.
Treating hyperlipidemia for the primary prevention of coronary disease. Are higher dosages of lovastatin cost-effective?
Perreault S, Hamilton VH, Lavoie F, Grover S. Perreault S, et al. Arch Intern Med. 1998 Feb 23;158(4):375-81. doi: 10.1001/archinte.158.4.375. Arch Intern Med. 1998. PMID: 9487235
Efficacy and costs of patient-controlled analgesia versus regularly administered intramuscular opioid therapy.
Choinière M, Rittenhouse BE, Perreault S, Chartrand D, Rousseau P, Smith B, Pepler C. Choinière M, et al. Among authors: perreault s. Anesthesiology. 1998 Dec;89(6):1377-88. doi: 10.1097/00000542-199812000-00015. Anesthesiology. 1998. PMID: 9856712 Clinical Trial.
Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
Perreault S, Dorais M, Coupal L, Paradis G, Joffres MR, Grover SA. Perreault S, et al. CMAJ. 1999 May 18;160(10):1449-55. CMAJ. 1999. PMID: 10352634 Free PMC article.
Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC. Perreault S, et al. Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):685-95. doi: 10.1002/pds.1068. Pharmacoepidemiol Drug Saf. 2005. PMID: 15645517
Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Moride Y, Ducruet T, Boivin JF, Moore N, Perreault S, Zhao S. Moride Y, et al. Among authors: perreault s. Arthritis Res Ther. 2005;7(2):R333-42. doi: 10.1186/ar1488. Epub 2005 Jan 17. Arthritis Res Ther. 2005. PMID: 15743481 Free PMC article.
Validation of a decision model for preventive pharmacological strategies in postmenopausal women.
Perreault S, Levinton C, Laurier C, Moride Y, Ste-Marie LG, Crott R. Perreault S, et al. Eur J Epidemiol. 2005;20(1):89-101. doi: 10.1007/s10654-004-9478-8. Eur J Epidemiol. 2005. PMID: 15756909
Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention.
Perreault S, Blais L, Lamarre D, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J. Perreault S, et al. Br J Clin Pharmacol. 2005 May;59(5):564-73. doi: 10.1111/j.1365-2125.2005.02355.x. Br J Clin Pharmacol. 2005. PMID: 15842555 Free PMC article.
Persistence with treatment in newly treated middle-aged patients with essential hypertension.
Perreault S, Lamarre D, Blais L, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J. Perreault S, et al. Ann Pharmacother. 2005 Sep;39(9):1401-8. doi: 10.1345/aph.1E548. Epub 2005 Aug 2. Ann Pharmacother. 2005. PMID: 16076920
291 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page